Lataa...
Sitagliptin ameliorates high glucose-induced cell proliferation and expression of the extracellular matrix in glomerular mesangial cells
Diabetic nephropathy (DN) is one of the most important causes that leads to end-stage renal disease and the efficacy of strategies currently available for the prevention of DN remains unsatisfactory. Sitagliptin (SIT), which is a dipeptidyl peptidase-4 inhibitor, exhibited a modest beneficial effect...
Tallennettuna:
| Julkaisussa: | Exp Ther Med |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5639317/ https://ncbi.nlm.nih.gov/pubmed/29042993 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.5002 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|